Camphor ungentum (Ointment) Instructions for Use
Marketing Authorization Holder
Tver Pharmaceutical Factory, PJSC (Russia)
ATC Code
M02AX10 (Other drugs)
Active Substance
Camphor (Ph.Eur. European Pharmacopoeia)
Dosage Form
| Camphor ungentum | Ointment for external use 10%: jar 25 or 50 g, tube 30 or 40 g |
Dosage Form, Packaging, and Composition
| Ointment for external use | 100 g |
| Camphor | 10 g |
Excipients: petrolatum 54 g, hard paraffin 8 g, anhydrous lanolin 28 g.
25 g – jars of orange glass (1) – cardboard packs.
50 g – jars of orange glass (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
40 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Analgesic and local anesthetic agent for external use
Pharmacotherapeutic Group
Local irritant of plant origin
Pharmacological Action
The drug of natural origin has antiseptic, local irritant, local analgesic, and anti-inflammatory effects.
By stimulating the sensitive nerve endings of the skin, it dilates blood vessels and improves the trophism of organs and tissues.
Pharmacokinetics
When applied to the skin surface, it is partially absorbed and undergoes oxidation.
The oxidation products combine with glucuronic acid and are excreted by the kidneys.
A part of camphor is excreted unchanged by the lungs and with bile.
Permeability through the blood-brain barrier and placental barrier is high; secretion with breast milk is high.
Indications
- Myalgia;
- Myositis;
- Arthralgia;
- Sciatica;
- Prevention of pressure sore formation.
ICD codes
| ICD-10 code | Indication |
| L89 | Decubitus ulcer and pressure area |
| M25.5 | Pain in joint |
| M54.1 | Radiculopathy |
| M54.3 | Sciatica |
| M54.4 | Lumbago with sciatica |
| M60 | Myositis |
| M79.1 | Myalgia |
| ICD-11 code | Indication |
| 8B93.Z | Radiculopathy, unspecified |
| 8E4A.1 | Paraneoplastic or autoimmune diseases of the peripheral or autonomic nervous system |
| EH90.Z | Pressure ulcer of unspecified degree |
| FB30 | Infectious myositis |
| FB32 | Other specified disorders of muscle |
| FB3Z | Disorder of muscle, unspecified |
| FB56.0 | Granuloma of soft tissue due to foreign body, not elsewhere classified |
| FB56.2 | Myalgia |
| ME82 | Pain in joint |
| ME84.20 | Lumbago with sciatica |
| ME84.3 | Sciatica |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply the ointment externally only.
Use a small amount of ointment on the painful area.
Rub the ointment into the skin with light, massaging movements.
Apply the ointment two to three times daily.
For prevention of pressure sores, treat the skin two to three times per day.
Always wash hands thoroughly after each application.
The standard treatment course is 7 to 10 days.
Undergo repeated courses only on the recommendation of a physician.
Avoid contact with open wounds, eyes, and mucous membranes.
Discontinue use and consult a physician if skin irritation or allergic reactions occur.
Adverse Reactions
Allergic skin reactions (urticaria), skin irritation, headache, dizziness.
Contraindications
- Impaired skin integrity or inflammatory skin diseases at the site of intended application (including dermatitis, eczema);
- Pregnancy;
- Lactation period;
- Age under 18 years (due to lack of data);
- Hypersensitivity.
Use in Pregnancy and Lactation
Contraindicated during pregnancy and lactation.
Pediatric Use
Contraindicated in children under 18 years of age.
Special Precautions
Avoid getting the drug on open wounds, in the eyes, and on mucous membranes.
Effect on the ability to drive vehicles and mechanisms
During the treatment period, caution should be exercised when driving motor vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
Overdose
To date, no cases of overdose with the use of the drug have been reported.
Drug Interactions
None identified.
Storage Conditions
Store at a temperature from 12°C (53.6°F) to 15°C (59°F), in a place protected from light.
Shelf Life
Shelf life – 4 years.
Do not use after the expiration date printed on the packaging.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Actovegin pills 200mg, 50pcs
Ingavirin capsules 90mg, 10pcs
Daivobet, ointment, 30g
Noopept, pills 10mg, 50pcs
OKI, sachets 80mg 2g, 12pcs
Fenotropil pills 100mg, 60pcs
Picamilon pills 50mg, 60pcs
Cortexin, 10mg, 5ml, 10pcs
Kagocel pills 12mg, 30pcs
Phenibut-Vertex pills 250mg, 20pcs
Belosalic, ointment, 30g
Cavinton Comfort, dispersible pills 10mg 90pcs
Arbidol, capsules 100mg, 40pcs
Nootropil pills 800mg, 30pcs 